Physician profile
Adrienne Mcmaster
NPI 1003095373
$682.55
in general payments reported to CMS, 2019-2025
11 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $17.05 · 2022: $232 · 2023: $128 · 2024: $197 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $353 · Education: $80.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $352.98 |
| Education | $80.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $179.26 | 2023-2024 | Vtama |
| Abbvie INC. | $115.94 | 2022-2025 | |
| Incyte Corporation | $83.68 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $80.86 | 2025 | Dupixent |
| Janssen Biotech, INC. | $67.01 | 2022-2023 | Tremfya |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $59.94 | 2022-2024 | Cabtreo, Jublia |
| Leo Pharma INC. | $23.33 | 2022 | |
| Genzyme Corporation | $22.77 | 2022 | |
| Lilly USA, LLC | $18.26 | 2023 | Taltz |
| Pfizer INC. | $17.05 | 2021 | |
| Galderma Laboratories, L.P. | $14.45 | 2023 | Aklief |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adrienne Mcmaster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.